MedPath

A Comparison of Stone Free Rate between Diuretics and Control Group in Patients Undergoing Extracorporeal Shock Wave Lithotripsy : A Prospective, Randomised, Double-Blind, Placebo-Controlled Trial

Phase 4
Recruiting
Conditions
rolithiasis patients treated with Extracorporeal Shock Wave Lithotripsy (ESWL).
Extracorporeal Shock Wave Lithotripsy (ESWL)
diuretics
Registration Number
TCTR20210601002
Lead Sponsor
/A
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
194
Inclusion Criteria

1.Urolithiasis patients treat with Extracorporeal Shock Wave Lithotripsy (ESWL)

Exclusion Criteria

1.Pregnancy
2.Serious Urinarytract infection
3.Coagulopathy
4.Severe Hypertension

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
stone free rate 3 months size of stone (millimetre)on Film X-ray plain Kidney Ureter Bladder
Secondary Outcome Measures
NameTimeMethod
treatment success rate 3 months size of residual stone (millimetre) on Film X-ray Kidney Ureter Bladder
© Copyright 2025. All Rights Reserved by MedPath